Indication
Growth Disorders
5 clinical trials
5 products
Product
SomavaratanProduct
rhGHClinical trial
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone DeficiencyStatus: Completed, Estimated PCD: 2017-08-23
Clinical trial
A Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children With Growth Hormone Deficiency in the First Year of TreatmentStatus: Recruiting, Estimated PCD: 2025-06-10
Product
SomatropinClinical trial
A Real-world Study of the Efficacy and Safety of PEGylated Recombinant Human Growth Hormone Injection in the Treatment of Short Stature in Chinese Children From the Global Registry for Novel Therapies For Rare Bone or Endocrine ConditionsStatus: Recruiting, Estimated PCD: 2029-01-01
Clinical trial
Growth Hormone in a Patient With a Dominant-Negative GHR MutationStatus: Active (not recruiting), Estimated PCD: 2023-09-01
Clinical trial
Identifying New Genetic Causes to the Disorders of Growth, Puberty and Sex DevelopmentStatus: Recruiting, Estimated PCD: 2027-02-21
Product
Blood sample